Is This the Key to Bevacizumab Use in CRC?
Dr. David Kerr reports on a plausible study suggesting a link between MMR-deficient colon tumors and response to bevacizumab in the adjuvant setting. (Source: Medscape Oncology)
Source: Medscape Oncology - September 16, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Is This the Key to Bevacizumab Use in CRC?
Dr. David Kerr reports on a plausible study suggesting a link between MMR-deficient colon tumors and response to bevacizumab in the adjuvant setting. (Source: Medscape General Surgery Podcast)
Source: Medscape General Surgery Podcast - September 16, 2013 Category: Surgery Authors: Medscape Source Type: podcasts
Dr. Roth Discusses the Treatment of Several Cancers With Bevacizumab
Bruce Roth, MD, Medical Oncologist, Professor of Medicine, Division of Oncology, Siteman Cancer Center, Washington University School of Medicine, discusses the treatment of several cancers with bevaci...
Author: feeds
Added: 09/05/2013 (Source: Oncology Tube)
Source: Oncology Tube - September 5, 2013 Category: Cancer & Oncology Source Type: podcasts
ASCO 2013: Cetuximab superior to bevacizumab for advanced colorectal cancer
Dr Volke Heinemann talks to ecancer managing editor, Prof Gordon McVie, at ASCO 2013 about the German phase III clinical trial FIRE-3.
The study found that first-line cetuximab plus FOLFIRI chemoth...
Author: feeds
Added: 08/30/2013 (Source: Oncology Tube)
Source: Oncology Tube - August 30, 2013 Category: Cancer & Oncology Source Type: podcasts
Radios and retinas
Since mobile phones have been around there has been public concern about their safety - fears over radiation exposure causing cancer have been particularly trenchant. This week Paul Elliott and his colleagues published research looking for an increase in the incidence of childhood cancers around mobile phone base stations. Paul joins us in the studio.
NCEPOD (the National Confidential Enquiry into Patient Outcome and Death) have published a report on parenteral nutrition. Kayte McCann talks to gastroenterologist Jim Stewart about the findings.
Finally, bevacizumab (traded as Avastin) has been used for off-label treatment o...
Source: The BMJ Podcast - August 29, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
ASCO 2013 - GOG Protocol240 Trial Updates - Dr. Krishnansu Tewari
Video interview with Dr. Krishnansu Tewari on Abstract 3#: Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic On...
Author: oncologyeducation
Added: 06/23/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 23, 2013 Category: Cancer & Oncology Source Type: podcasts
Avastin-containing regimen for first line and maintenance therapy in advanced NSCLC
http://cancerGRACE.org/...
Drs. Nate Pennell, Mary Pinder, and Jack West review the results presented at ASCO 2013 from the PARAMOUNT trial of maintenance therapy with the ECOG 4599 regimen vs. carbop...
Author: cancergrace
Added: 06/17/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 17, 2013 Category: Cancer & Oncology Source Type: podcasts
Do you need Avastin in first line and maintenance therapy in advanced NSCLC?
http://cancerGRACE.org/...
Drs. Nate Pennell, Mary Pinder, and Jack West review the results presented at ASCO 2013 from the PRONOUNCE trial of the ECOG 4599 trial regimen compared with carboplatin/Ali...
Author: cancergrace
Added: 06/14/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 14, 2013 Category: Cancer & Oncology Source Type: podcasts
Study offers new insights for bevacizumab use in patients with brain cancer
Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life, and these changes often predict treatment outcom...
Author: mdanderson
Added: 06/04/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2013 Category: Cancer & Oncology Source Type: podcasts
Test helps identify glioblastoma patients most likely to benefit from drug
A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin®), according to new research from The University of Texas MD Anderson Cancer Center.
Author: mdanderson
Added: 06/04/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2013 Category: Cancer & Oncology Source Type: podcasts
Recent study on drug for newly diagnosed glioblastoma patients
Download from iTunes: https://itunes.apple.com/us.... Bevacizumab offers no benefit for newly diagnosed glioblastoma (brain) cancer patient...
Author: mdanderson
Added: 06/04/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2013 Category: Cancer & Oncology Source Type: podcasts
Topol Talks to Ferrara, $3M Breakthrough Prize Winner
Dr. Eric Topol talks with Dr. Napoleone Ferrara, recent winner of the Breakthrough Prize in Life Sciences and the researcher whose work led to the synthesis of bevacizumab and ranibizumab. (Source: Medscape Allergy and Immunology Podcast)
Source: Medscape Allergy and Immunology Podcast - May 2, 2013 Category: Allergy & Immunology Authors: Medscape Source Type: podcasts
Topol Talks to Ferrara, $3M Breakthrough Prize Winner
Dr. Eric Topol talks with Dr. Napoleone Ferrara, recent winner of the Breakthrough Prize in Life Sciences and the researcher whose work led to the synthesis of bevacizumab and ranibizumab. (Source: Medscape Critical Care Podcast)
Source: Medscape Critical Care Podcast - May 2, 2013 Category: Intensive Care Authors: Medscape Source Type: podcasts
